Small Channels, Smarter Delivery – A Practical Boost For Topical And Regenerative Approaches
Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now clascoterone and exosome solutions) by delivering actives to the follicular dermis. Practical protocol highlights: shave the field, use topical anesthesia, prefer a 1.5 mm dermaroller moved until pinpoint bleeding, delay topical application ~24 hours, and repeat about every four weeks for several months. Side effects are typically mild and transient; serious complications are rare when contraindications (bleeding disorders, active infection, keloid tendency) are respected. Early data also suggest MN is a promising conduit for hair‑follicle stem cell grafts and scaffolded implants, but those approaches are still experimental. Want the protocol details, outcome numbers, and guidance on which patients to offer this to? Read the full article – it’s practical, data‑driven, and immediately relevant to clinic practice.
J Drugs Dermatol. 2025;24(10): doi:10.36849/JDD.09076
Blog write-up assisted by AI
